{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:33:52Z","timestamp":1778693632728,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>BK virus-associated nephropathy (BKVAN) is a relatively common cause of renal dysfunction in the first six months after renal transplantation. It arises from reactivation of the latent and usually harmless BK virus (BK virus) due to immunosuppression and other factors including some that are unique to renal transplantation such as allograft injury. BKVAN is much rarer in non-renal solid organ transplantation, where data regarding diagnosis and management are extremely limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a case of a 58-year-old man found to have worsening renal dysfunction nine months after bilateral sequential lung transplantation for chronic obstructive pulmonary disease (COPD). He had required methylprednisolone for acute allograft rejection but achieved good graft function. Urine microscopy and culture and renal ultrasound were normal. BK virus PCR was positive at high levels in urine and blood. Renal biopsy subsequently confirmed BKVAN. The patient progressed to end-stage renal failure requiring haemodialysis despite reduction in immunosuppression, including switching mycophenolate for everolimus, and the administration of intravenous immunoglobulin (IVIG).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This very rare case highlights the challenges presented by BK virus in the non-renal solid organ transplant population. Diagnosis can be difficult, especially given the heterogeneity with which BKV disease has been reported to present in such patients, and the optimal approach to management is unknown. Balancing reduction in immunosuppression against prevention of allograft rejection is delicate. Improved therapeutic options are clearly required.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05292-0","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:03:00Z","timestamp":1597410180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["BK virus-associated nephropathy in a lung transplant patient: case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4873-5439","authenticated-orcid":false,"given":"Thomas","family":"Crowhurst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall","family":"Faull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Li","family":"Holmes-Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"5292_CR1","doi-asserted-by":"publisher","unstructured":"Viswesh V, Yost SE, Kaplan B. The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: A systematic review. Transplant Rev (Orlando). 2015;29(3):175\u2013180. doi: 1https:\/\/doi.org\/10.1016\/j.trre.2015.1002.1004. Epub 2015 Feb 1024.","DOI":"10.1016\/j.trre.2015.1002.1004"},{"key":"5292_CR2","doi-asserted-by":"publisher","unstructured":"Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71(1):115\u2013123. doi: 1https:\/\/doi.org\/10.1002\/jmv.10450.","DOI":"10.1002\/jmv.10450"},{"key":"5292_CR3","doi-asserted-by":"crossref","unstructured":"Polo C, Perez JL, Mielnichuck A, Fedele CG, Niubo J, Tenorio A. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect. 2004;10(7):640\u2013644. doi: 610.1111\/j.1469\u20130691.2004.00882.x.","DOI":"10.1111\/j.1469-0691.2004.00882.x"},{"key":"5292_CR4","doi-asserted-by":"publisher","unstructured":"Manzano Sanchez D, Jimeno Garcia L, Manzano Sanchez D, et al. Renal function impairment in kidney transplantation: importance of early BK virus detection. Transplant Proc. 2019;51(2):350\u2013352. doi: 3https:\/\/doi.org\/10.1016\/j.transproceed.2018.1012.1016. Epub 2018 Dec 1030.","DOI":"10.1016\/j.transproceed.2018.1012.1016"},{"key":"5292_CR5","doi-asserted-by":"crossref","unstructured":"Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582\u2013594. doi: 510.1111\/j.1600\u20136143.2005.00742.x.","DOI":"10.1111\/j.1600-6143.2005.00742.x"},{"key":"5292_CR6","doi-asserted-by":"publisher","unstructured":"Nickeleit V, Singh HK, Randhawa P, et al. The banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol. 2018;29(2):680\u2013693. doi: 6https:\/\/doi.org\/10.1681\/ASN.2017050477. Epub 2017052017 Dec 2017050426.","DOI":"10.1681\/ASN.2017050477"},{"key":"5292_CR7","doi-asserted-by":"publisher","unstructured":"Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019\u20131026. doi: 10https:\/\/doi.org\/10.1097\/TP.1010b1013e31819cc31383.","DOI":"10.1097\/TP.1010b1013e31819cc31383"},{"key":"5292_CR8","doi-asserted-by":"crossref","unstructured":"Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013;13(1):136\u2013145. doi: 110.1111\/j.1600\u20136143.2012.04320.x. Epub 02012 Nov 04328.","DOI":"10.1111\/j.1600-6143.2012.04320.x"},{"key":"5292_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.1010.1002","volume":"109","author":"B Demey","year":"2018","unstructured":"Demey B, Tinez C, Francois C, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review. J Clin Virol. 2018;109:6\u201312. https:\/\/doi.org\/10.1016\/j.jcv.2018.1010.1002 Epub 2018 Oct 1012.","journal-title":"J Clin Virol"},{"key":"5292_CR10","doi-asserted-by":"crossref","unstructured":"Pastrana DV, Brennan DC, Cuburu N, et al. Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog. 2012;8(4):e1002650. doi: 1002610.1001371\/journal.ppat.1002650. Epub 1002012 Apr 1002612.","DOI":"10.1371\/journal.ppat.1002650"},{"key":"5292_CR11","doi-asserted-by":"publisher","unstructured":"Martin-Gandul C, Mueller NJ, Pascual M, Manuel O. The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation. Am J Transplant. 2015;15(12):3024\u20133040. doi: 30https:\/\/doi.org\/10.1111\/ajt.13486. Epub 12015 Oct 13416.","DOI":"10.1111\/ajt.13486"},{"key":"5292_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.12659\/AOT.908429","volume":"23","author":"MJ Barten","year":"2018","unstructured":"Barten MJ, Zuckermann A. BK virus: a cause for concern in thoracic transplantation? Ann Transplant. 2018;23:310\u201321. https:\/\/doi.org\/10.12659\/AOT.908429.","journal-title":"Ann Transplant"},{"key":"5292_CR13","doi-asserted-by":"publisher","unstructured":"Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13528. doi: 135https:\/\/doi.org\/10.11111\/ctr.13528. Epub 12019 Apr 13510.","DOI":"10.11111\/ctr.13528"},{"key":"5292_CR14","doi-asserted-by":"publisher","unstructured":"Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009;20(2):416\u2013427. doi: 4https:\/\/doi.org\/10.1681\/ASN.2008010117. Epub 2008012009 Jan 2008010121.","DOI":"10.1681\/ASN.2008010117"},{"key":"5292_CR15","doi-asserted-by":"publisher","unstructured":"Singh HK, Reisner H, Derebail VK, Kozlowski T, Nickeleit V. Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease. Transplantation. 2015;99(3):609\u2013615. doi: 6https:\/\/doi.org\/10.1097\/TP.0000000000000367.","DOI":"10.1097\/TP.0000000000000367"},{"key":"5292_CR16","doi-asserted-by":"publisher","unstructured":"Wiseman AC. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis. 2009;54(1):131\u2013142. doi: 1https:\/\/doi.org\/10.1053\/j.ajkd.2009.1001.1271. Epub 2009 Apr 1025.","DOI":"10.1053\/j.ajkd.2009.1001.1271"},{"key":"5292_CR17","doi-asserted-by":"publisher","unstructured":"Moscarelli L, Caroti L, Antognoli G, et al. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience. Clin Transplant. 2013;27(4):546\u2013554. doi: 5https:\/\/doi.org\/10.1111\/ctr.12151. Epub 12013 Jun 12113.","DOI":"10.1111\/ctr.12151"},{"key":"5292_CR18","doi-asserted-by":"publisher","unstructured":"Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F. Mycophenolate mofetil withdrawal with conversion to everolimus to treat BK virus infection in kidney transplant recipients. Transplant Proc. 2017;49(8):1773\u20131778. doi: 17https:\/\/doi.org\/10.1016\/j.transproceed.2017.1706.1030.","DOI":"10.1016\/j.transproceed.2017.1706.1030"},{"key":"5292_CR19","doi-asserted-by":"publisher","unstructured":"Knoll GA, Humar A, Fergusson D, et al. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA. 2014;312(20):2106\u20132114. doi: 21https:\/\/doi.org\/10.1001\/jama.2014.14721.","DOI":"10.1001\/jama.2014.14721"},{"key":"5292_CR20","doi-asserted-by":"publisher","unstructured":"Papanicolaou GA, Lee YJ, Young JW, et al. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. Am J Kidney Dis. 2015;65(5):780\u2013784. doi: 7https:\/\/doi.org\/10.1053\/j.ajkd.2014.1011.1020. Epub 2015 Jan 1017.","DOI":"10.1053\/j.ajkd.2014.1011.1020"},{"key":"5292_CR21","doi-asserted-by":"publisher","unstructured":"Tzannou I, Papadopoulou A, Naik S, et al. Off-the-shelf virus-specific T cells to treat BK Virus, Human herpesvirus 6, cytomegalovirus, epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35(31):3547\u20133557. doi: 35https:\/\/doi.org\/10.1200\/JCO.2017.3573.0655. Epub 2017 Aug 3547.","DOI":"10.1200\/JCO.2017.3573.0655"},{"key":"5292_CR22","doi-asserted-by":"crossref","unstructured":"Schwarz A, Mengel M, Haller H, Niedermeyer J. Polyoma virus nephropathy in native kidneys after lung transplantation. Am J Transplant. 2005;5(10):2582\u20132585. doi: 2510.1111\/j.1600\u20136143.2005.01043.x.","DOI":"10.1111\/j.1600-6143.2005.01043.x"},{"key":"5292_CR23","doi-asserted-by":"crossref","unstructured":"Egli A, Helmersen DS, Taub K, Hirsch HH, Johnson A. Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. Am J Transplant. 2010;10(10):2324\u20132330. doi: 2310.1111\/j.1600\u20136143.2010.03265.x. Epub 02010 Sep 03214.","DOI":"10.1111\/j.1600-6143.2010.03265.x"},{"key":"5292_CR24","doi-asserted-by":"publisher","unstructured":"Dufek S, Haitel A, Muller-Sacherer T, Aufricht C. Duct Bellini carcinoma in association with BK virus nephropathy after lung transplantation. J Heart Lung Transplant. 2013;32(3):378\u2013379. doi: 3https:\/\/doi.org\/10.1016\/j.healun.2012.1011.1033. Epub 2013 Jan 1012.","DOI":"10.1016\/j.healun.2012.1011.1033"},{"key":"5292_CR25","doi-asserted-by":"publisher","unstructured":"Sharma SG, Nickeleit V, Herlitz LC, et al. BK polyoma virus nephropathy in the native kidney. Nephrol Dial Transplant. 2013;28(3):620\u2013631. doi: 6https:\/\/doi.org\/10.1093\/ndt\/gfs1537. Epub 2012 Dec 1018.","DOI":"10.1093\/ndt\/gfs1537"},{"key":"5292_CR26","doi-asserted-by":"publisher","unstructured":"Vigil D, Konstantinov NK, Barry M, et al. BK nephropathy in the native kidneys of patients with organ transplants: clinical spectrum of BK infection. World J Transplant. 2016;6(3):472\u2013504. doi: 4https:\/\/doi.org\/10.5500\/wjt.v5506.i5503.5472.","DOI":"10.5500\/wjt.v5506.i5503.5472"},{"key":"5292_CR27","doi-asserted-by":"publisher","unstructured":"Kuppachi S, Holanda D, Eberlein M, et al. An unexpected surge in plasma BKPyV viral load heralds the development of BKPyV-Associated metastatic bladder cancer in a lung transplant recipient with BKPyV nephropathy. Am J Transplant. 2017;17(3):813\u2013818. doi: 8https:\/\/doi.org\/10.1111\/ajt.14057. Epub 12016 Oct 14021.","DOI":"10.1111\/ajt.14057"},{"key":"5292_CR28","doi-asserted-by":"publisher","unstructured":"Okumura J, Nakahara Y, Nakaguro M, et al. BK virus-associated viruria and viremia in a patient with lymphangioleiomyomatosis after lung re-transplantation: A case report and review of the literature on BK virus infection post-lung transplantation. J Infect Chemother. 2019;25(10):820\u2013824. doi: 8https:\/\/doi.org\/10.1016\/j.jiac.2019.1004.1002. Epub 2019 Apr 1023.","DOI":"10.1016\/j.jiac.2019.1004.1002"},{"key":"5292_CR29","doi-asserted-by":"crossref","unstructured":"Elidemir O, Chang IF, Schecter MG, Mallory GB. BK virus-associated hemorrhagic cystitis in a pediatric lung transplant recipient. Pediatr Transplant. 2007;11(7):807\u2013810. doi: 810.1111\/j.1399\u20133046.2007.00778.x.","DOI":"10.1111\/j.1399-3046.2007.00778.x"},{"key":"5292_CR30","doi-asserted-by":"crossref","unstructured":"Barton TD, Blumberg EA, Doyle A, et al. A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis. 2006;8(2):102\u2013107. doi: 110.1111\/j.1399\u20133062.2006.00155.x.","DOI":"10.1111\/j.1399-3062.2006.00155.x"},{"key":"5292_CR31","doi-asserted-by":"publisher","unstructured":"Thomas LD, Vilchez RA, White ZS, et al. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis. 2007;195(3):442\u2013449. doi: 4https:\/\/doi.org\/10.1086\/510625. Epub 512006 Dec 510622.","DOI":"10.1086\/510625"},{"key":"5292_CR32","doi-asserted-by":"publisher","unstructured":"Doucette KE, Pang XL, Jackson K, et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation. 2008;85(12):1733\u20131736. doi: 17https:\/\/doi.org\/10.1097\/TP.1730b1013e3181722ead.","DOI":"10.1097\/TP.1730b1013e3181722ead"},{"key":"5292_CR33","doi-asserted-by":"publisher","unstructured":"Thomas LD, Milstone AP, Vilchez RA, Zanwar P, Butel JS, Dummer JS. Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation. Transplantation. 2009;88(3):360\u2013366. doi: 3https:\/\/doi.org\/10.1097\/TP.1090b1013e3181ae1095ff1099.","DOI":"10.1097\/TP.1090b1013e3181ae1095ff1099"},{"key":"5292_CR34","doi-asserted-by":"publisher","unstructured":"Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis. 2005;192(8):1349\u20131354. doi: 13https:\/\/doi.org\/10.1086\/466532. Epub 462005 Sep 466514.","DOI":"10.1086\/466532"},{"key":"5292_CR35","doi-asserted-by":"publisher","unstructured":"Salama M, Boudville N, Speers D, Jeffrey GP, Ferrari P. Decline in native kidney function in liver transplant recipients is not associated with BK virus infection. Liver Transpl. 2008;14(12):1787\u20131792. doi: 17https:\/\/doi.org\/10.1002\/lt.21627.","DOI":"10.1002\/lt.21627"},{"key":"5292_CR36","doi-asserted-by":"publisher","unstructured":"Loeches B, Valerio M, Palomo J, Bouza E, Munoz P. BK virus in heart transplant recipients: a prospective study. J Heart Lung Transplant. 2011;30(1):109\u2013111. doi: 1https:\/\/doi.org\/10.1016\/j.healun.2010.1008.1028. Epub 2010 Oct 1016.","DOI":"10.1016\/j.healun.2010.1008.1028"},{"key":"5292_CR37","doi-asserted-by":"publisher","unstructured":"Milstone A, Vilchez RA, Geiger X, Fogo AB, Butel JS, Dummer S. Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant recipient. Transplantation. 2004;77(7):1019\u20131024. doi: 10https:\/\/doi.org\/10.1097\/1001.tp.0000119156.0000152197.ca.","DOI":"10.1097\/1001.tp.0000119156.0000152197.ca"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05292-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05292-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05292-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T23:14:10Z","timestamp":1667776450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05292-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5292"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05292-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written patient consent has been obtained for the publication of this manuscript and associated images. Given that the preparation of this case report only required retrospective review of existing clinical data, ethics approval from an ethics committee was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written patient consent has been obtained for the publication of this manuscript and associated images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no completing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"600"}}